219 related articles for article (PubMed ID: 35176709)
1. Purendan alleviates non-alcoholic fatty liver disease in aged type 2 diabetic rats via regulating mTOR/S6K1/SREBP-1c signaling pathway.
Fan L; Niu H; Zhao L; Yao R; He X; Lu B; Pang Z
Biomed Pharmacother; 2022 Apr; 148():112697. PubMed ID: 35176709
[TBL] [Abstract][Full Text] [Related]
2. [Diosgenin alleviates NAFLD induced by a high-fat diet in rats via mTOR/SREBP-1c/HSP60/MCAD/SCAD signaling pathway].
Chen SW; Yin GL; Song CY; Meng DC; Yu WF; Zhang X; Feng YN; Liang PP; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Oct; 48(19):5304-5314. PubMed ID: 38114120
[TBL] [Abstract][Full Text] [Related]
3. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
4. [Effect of diosgenin on mTOR/FASN/HIF-1α/VEGFA expression in rats with non-alcoholic fatty liver disease].
Yin GL; Liang HY; Liang PP; Feng YN; Chen SW; Liu XY; Pan WC; Zhang FX
Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1760-1769. PubMed ID: 37282950
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway.
Hu J; Hong W; Yao KN; Zhu XH; Chen ZY; Ye L
World J Gastroenterol; 2019 Mar; 25(12):1492-1501. PubMed ID: 30948912
[TBL] [Abstract][Full Text] [Related]
6. [Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1].
Zheng H; Hong SC; Yu J; Wen XY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):846-52. PubMed ID: 25137852
[TBL] [Abstract][Full Text] [Related]
7. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
8. [Zuogui Jiangtang Qinggan Formula improves glucolipid metabolism in type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease by regulating FoxO1/MTP/APOB signaling pathway].
Xiang YX; Huang YL; Zhou M; Zou JJ; Liu X; Liu ZY; Xiao F; Yu R; Xiang Q
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4438-4445. PubMed ID: 37802870
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Zuogui Jiangtang Qinggan Formula on lipid metabolism in db/db mouse model of type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease].
Zhou M; Li L; Zou JJ; Liu X; Wu YJ; Xiang Q; Yu R
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(6):1587-1593. PubMed ID: 38621943
[TBL] [Abstract][Full Text] [Related]
10. Mori Cortex extract ameliorates nonalcoholic fatty liver disease (NAFLD) and insulin resistance in high-fat-diet/streptozotocin-induced type 2 diabetes in rats.
Ma LL; Yuan YY; Zhao M; Zhou XR; Jehangir T; Wang FY; Xi Y; Bu SZ
Chin J Nat Med; 2018 Jun; 16(6):411-417. PubMed ID: 30047462
[TBL] [Abstract][Full Text] [Related]
11. Phloridzin Ameliorates Lipid Deposition in High-Fat-Diet-Fed Mice with Nonalcoholic Fatty Liver Disease
Liu H; Chen Y; Wen Y; Zhu S; Huang S; He L; Hou S; Lai X; Chen S; Dai Z; Liang J
J Agric Food Chem; 2021 Aug; 69(31):8671-8683. PubMed ID: 34342231
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of effects of oleic acid and palmitic acid on lipid deposition and mTOR / S6K1 / SREBP-1c pathway in HepG2 cells].
Zhou YP; Wu R; Shen W; Yu HH; Yu SJ
Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):451-456. PubMed ID: 30317760
[No Abstract] [Full Text] [Related]
13. Down-regulation of lncRNA-NEAT1 alleviated the non-alcoholic fatty liver disease via mTOR/S6K1 signaling pathway.
Wang X
J Cell Biochem; 2018 Feb; 119(2):1567-1574. PubMed ID: 28771824
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Fuzi Lizhong decoction in reducing liver injury of rats with non-alcoholic fatty liver via activating AMPK and suppressing NF-κBp65 pathway].
Yang JY; Shi ZH; Ma W; Tao DQ; Liu S; Chen L; Zhou XL
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3176-3183. PubMed ID: 30200715
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
16. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
[TBL] [Abstract][Full Text] [Related]
17. [Effects of soothing liver and invigorating spleen recipes on SREBP-1c, SCD-1 mRNA and proteins expression in hepatocytes of NAFLD rats].
Xu YJ; Yang QH; Han L; Zhang YP; Liu YZ; Jin L; Yan HZ
Zhong Yao Cai; 2014 Jan; 37(1):80-6. PubMed ID: 25090711
[TBL] [Abstract][Full Text] [Related]
18. The PKA-SREBP1c Pathway Plays a Key Role in the Protective Effects of Lactobacillus johnsonii JNU3402 Against Diet-Induced Fatty Liver in Mice.
Hong E; Kang H; Yang G; Oh S; Kim E
Mol Nutr Food Res; 2023 Oct; 67(20):e2200496. PubMed ID: 37650271
[TBL] [Abstract][Full Text] [Related]
19. Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway.
Zhu X; Bian H; Wang L; Sun X; Xu X; Yan H; Xia M; Chang X; Lu Y; Li Y; Xia P; Li X; Gao X
Free Radic Biol Med; 2019 Sep; 141():192-204. PubMed ID: 31226399
[TBL] [Abstract][Full Text] [Related]
20. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
Shi C; Xue W; Han B; Yang F; Yin Y; Hu C
Eur J Pharmacol; 2019 May; 850():15-22. PubMed ID: 30753863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
